Form 8-K - Current report:
SEC Accession No. 0001104659-24-129159
Filing Date
2024-12-17
Accepted
2024-12-17 06:31:17
Documents
15
Period of Report
2024-12-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430433d3_8k.htm   iXBRL 8-K 25813
2 EXHIBIT 99.1 tm2430433d3_ex99-1.htm EX-99.1 11638
6 GRAPHIC tm2430433d3_ex99-1img01.jpg GRAPHIC 4327
  Complete submission text file 0001104659-24-129159.txt   219284

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lmat-20241216.xsd EX-101.SCH 3003
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lmat-20241216_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lmat-20241216_pre.xml EX-101.PRE 22351
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2430433d3_8k_htm.xml XML 3688
Mailing Address 63 SECOND AVENUE BURLINGTON MA 01803
Business Address 63 SECOND AVENUE BURLINGTON MA 01803 781-221-2266
LEMAITRE VASCULAR INC (Filer) CIK: 0001158895 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33092 | Film No.: 241553612
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)